Type 2 Diabetes Patients with Metabolic-associated Fatty Liver Disease(T2DM-MAFLD)
Conditions
Interventions
Sponsors
People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Diagnosis of Type 2 Diabetes Mellitus combined with Metabolic-associated Fatty Liver Disease (T2DM-MAFLD); (2) Availability of complete patient information, clinical data, and Traditional Chinese Medicine (TCM) constitution classification data in the database; (3) Presence of comprehensive cardiovascular risk factor data in the database; (4) Age between 18 and 75 years.
Exclusion criteria
Exclusion criteria: (1) Patient records with incomplete or poor-quality data; (2) Patients with severe heart, lung, liver, or kidney failure or advanced-stage malignancies; (3) Pregnant or lactating women; (4) Patients with acute hepatitis, severe hepatitis, decompensated cirrhosis, or hepatocellular carcinoma; (5) Patients with specific diseases that may cause fatty liver, such as viral hepatitis, drug-induced liver injury, total parenteral nutrition, Wilson's disease, or autoimmune liver diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiovascular Risk Assessment-Framingham score;Cardiovascular Risk Assessment-ADVANCE score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Basic Information;TCM Four Diagnostic Examination Data;Liver function;Glucose Metabolic Indicators;Lipid Metabolism Indicators;Kidney Function Indicators;Ultrasonography (Liver, Cervical Vessels, and Lower Limb Vessels); | — |
Countries
China
Contacts
Public ContactMingqian Jiang
People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine
Outcome results
None listed